![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: McKeage Kate Keam Susan J.
Publisher: Adis International
ISSN: 0012-6667
Source: Drugs, Vol.65, Iss.16, 2005-01, pp. : 2287-2294
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Docetaxel in Hormone-Refractory Metastatic Prostate Cancer: A Viewpoint by William R. Berry
Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cabazitaxel: A Novel Drug for Hormone-Refractory Prostate Cancer
Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Eton David T. Shevrin Daniel H. Beaumont Jennifer Victorson David Cella David
Value in Health, Vol. 13, Iss. 5, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment Options in Hormone-Refractory Prostate Cancer: Current and Future Approaches
Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. :